Skip to main content

Market Overview

50 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Share:

Gainers

  • Midatech Pharma, Inc. (NASDAQ: MTP) stock moved upwards by 93.8% to $1.32 during Wednesday's pre-market session.
  • InVivo Therapeutics Hldg, Inc. (NASDAQ: NVIV) stock rose 31.0% to $0.38.
  • Applied Therapeutics, Inc. (NASDAQ: APLT) stock surged 25.0% to $32.69.
  • Verastem Oncology, Inc. (NASDAQ: VSTM) shares moved upwards by 15.1% to $1.45.
  • vTv Therapeutics, Inc. (NASDAQ: VTVT) stock moved upwards by 6.5% to $1.89.
  • Bio-Path Holdings, Inc. (NASDAQ: BPTH) stock rose 5.7% to $8.30. The most recent rating by H.C. Wainwright, on December 02, is at Buy, with a price target of $25.00.
  • BioNTech, Inc. (NASDAQ: BNTX) stock increased by 5.1% to $45.55. The most recent rating by Wolfe Research, on November 05, is at Outperform, with a price target of $21.00.
  • Personalis, Inc. (NASDAQ: PSNL) stock surged 5.0% to $11.45. The most recent rating by Morgan Stanley, on November 15, is at Overweight, with a price target of $16.00.
  • CannTrust Holdings, Inc. (NYSE: CTST) shares increased by 4.8% to $1.09.
  • Xenetic Biosciences, Inc. (NASDAQ: XBIO) stock increased by 4.8% to $1.54.
  • AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) shares rose 4.4% to $0.71.
  • Kala Pharmaceuticals, Inc. (NASDAQ: KALA) stock increased by 4.4% to $4.50. According to the most recent rating by Bank of America, on December 17, the current rating is at Neutral.
  • Achieve Life Sciences, Inc. (NASDAQ: ACHV) stock surged 4.0% to $0.58.
  • Akorn, Inc. (NASDAQ: AKRX) stock rose 4.0% to $1.30.
  • Vascular Biogenics, Inc. (NASDAQ: VBLT) stock rose 4.0% to $1.30.
  • Solid Biosciences, Inc. (NASDAQ: SLDB) shares moved upwards by 3.9% to $4.49. The most recent rating by Nomura, on December 19, is at Buy, with a price target of $10.00.
  • KemPharm, Inc. (NASDAQ: KMPH) shares moved upwards by 3.7% to $0.56. The most recent rating by H.C. Wainwright, on November 20, is at Buy, with a price target of $2.50.
  • TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) shares rose 3.7% to $2.54. The most recent rating by H.C. Wainwright, on December 23, is at Buy, with a price target of $18.00.
  • Guardion Health Sciences, Inc. (NASDAQ: GHSI) stock increased by 3.6% to $0.37.
  • Anavex Life Sciences, Inc. (NASDAQ: AVXL) shares moved upwards by 3.5% to $3.00.
  • SCYNEXIS, Inc. (NASDAQ: SCYX) stock increased by 3.3% to $0.93.
  • Kitov Pharma, Inc. (NASDAQ: KTOV) shares rose 3.1% to $0.82.
  • Microbot Medical, Inc. (NASDAQ: MBOT) stock surged 2.7% to $11.87. The most recent rating by H.C. Wainwright, on December 24, is at Buy, with a price target of $12.00.
  • Novan, Inc. (NASDAQ: NOVN) stock rose 2.7% to $0.77. The most recent rating by H.C. Wainwright, on January 06, is at Buy, with a price target of $1.50.
  • DBV Technologies, Inc. (NASDAQ: DBVT) shares moved upwards by 2.5% to $11.44. The most recent rating by Citigroup, on December 16, is at Buy, with a price target of $14.00.

 

Losers

  • Genetic Technologies, Inc. (NASDAQ: GENE) stock declined 18.0% to $3.70 during Wednesday's pre-market session.
  • NeuroMetrix, Inc. (NASDAQ: NURO) shares declined 9.6% to $3.35.
  • Genprex, Inc. (NASDAQ: GNPX) shares decreased by 9.5% to $0.38.
  • ContraFect, Inc. (NASDAQ: CFRX) stock plummeted 9.0% to $0.78.
  • Ocugen, Inc. (NASDAQ: OCGN) stock fell 7.2% to $0.59. According to the most recent rating by H.C. Wainwright, on December 20, the current rating is at Buy.
  • Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) stock decreased by 6.8% to $0.22. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
  • Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) shares decreased by 6.8% to $28.90. The most recent rating by Canaccord Genuity, on December 24, is at Buy, with a price target of $65.00.
  • Outlook Therapeutics, Inc. (NASDAQ: OTLK) shares plummeted 6.5% to $0.82.
  • Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) shares decreased by 6.3% to $0.22.
  • Walgreens Boots Alliance, Inc. (NASDAQ: WBA) stock decreased by 5.8% to $55.85. The most recent rating by SunTrust Robinson Humphrey, on December 18, is at Hold, with a price target of $60.00.
  • Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) shares fell 5.4% to $0.19.
  • Acorda Therapeutics, Inc. (NASDAQ: ACOR) stock plummeted 4.9% to $2.32. According to the most recent rating by JP Morgan, on October 24, the current rating is at Underweight.
  • Diffusion Pharmaceuticals, Inc. (NASDAQ: DFFN) stock decreased by 4.9% to $0.48. The most recent rating by H.C. Wainwright, on December 18, is at Buy, with a price target of $3.50.
  • Correvio Pharma, Inc. (NASDAQ: CORV) shares declined 4.9% to $0.39. According to the most recent rating by H.C. Wainwright, on December 11, the current rating is at Neutral.
  • Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) stock plummeted 4.4% to $4.11.
  • Aethlon Medical, Inc. (NASDAQ: AEMD) stock decreased by 4.3% to $1.10.
  • Tyme Technologies, Inc. (NASDAQ: TYME) stock fell 4.0% to $1.68.
  • Proteostasis Therapeutics, Inc. (NASDAQ: PTI) stock decreased by 4.0% to $2.16.
  • Conatus Pharmaceuticals, Inc. (NASDAQ: CNAT) shares plummeted 3.9% to $0.41.
  • Cassava Sciences, Inc. (NASDAQ: SAVA) stock fell 3.5% to $7.43. The most recent rating by H.C. Wainwright, on December 06, is at Buy, with a price target of $6.00.
  • Acasti Pharma, Inc. (NASDAQ: ACST) stock declined 3.0% to $2.26. The most recent rating by B. Riley FBR, on November 18, is at Buy, with a price target of $8.00.
  • Cellect Biotechnology, Inc. (NASDAQ: APOP) stock declined 2.9% to $3.97.
  • NewLink Genetics, Inc. (NASDAQ: NLNK) shares declined 2.8% to $2.06.
  • Advaxis, Inc. (NASDAQ: ADXS) stock plummeted 2.3% to $1.27.
  • SeaSpine Holdings, Inc. (NASDAQ: SPNE) shares fell 2.2% to $12.75. According to the most recent rating by Wells Fargo, on December 12, the current rating is at Underweight.
 

Related Articles (ACOR + ACHV)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com